exam 1 - genetic testing Flashcards

1
Q

A 41 yo G3 P1011 LMP 6 weeks ago presents for prenatal care and states, “I want to tell you I don’t believe in that genetic testing. This baby is a gift from God and I will accept them the way God made them; so those tests won’t have any impact on me. I don’t want them.”

A

You counsel the patient about available options for genetic testing, telling her that they has no obligation to have such testing, but you explain to her the possible benefits of being tested. After listening to what you have to say, she decides to undergo cell-free DNA testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

complex issues to consider when recommending genetic testing

A

-Potential for “wrongful life” lawsuits in obstetric cases
-Rights of the disabled
-Sensitivity and specificity of genetic testing
-Potential for unnecessary invasive procedures based on results, especially with obstetrical testing
-Guilt about results
-document that pt declined and was educated
-Genetic discrimination
-Genetic Information Nondiscrimination Act of 2008 (GINA)
-Potential for employer discrimination
-Potential for discrimination with health, disability, and life insurance
-Privacy matters- HIPAA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

statistics concerning chromosomal anomalies in pregnancy

A

-approx 1:150 live births have an abnormal phenotype
-about 20% of infant deaths are due to chromosomal abnormality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

risk factors associated with genetic anomalies

A

-advanced maternal age (35+)
-advanced paternal age (40-50+)
-prior history of child with birth defect
-prior hx of child with genetic disorder
-parent with known genetic disorder
-parental carrier status of a genetic disorder
-pregnancy with identified structural anomaly identified by US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

reasons by you genetic test

A

-if pt says they will love the baby no matter what
-you can halt or help the baby earlier or identify health problems earlier to help the child -> better outcomes
-down syndrome 1:700 -> heart anomaly are common -> help the child or be prepared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

screening vs. dx testing

A

-understand the difference
-screening- identifies a group of pts at risk of a particular condition
-tolerable to the pt
-relatively inexpensive
-easy to perform
-high sensitivity and specificity
-dx testing renders a dx of a particular condition:
-invasive test is required
-preimplantation genetic dx
-chorionic villus sampling
-amniocentesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

preimplantation genetic testing

A

-Non-invasive testing:
-Uses cell-free DNA obtained during culture
-87-100% accurate
-Invasive testing:
-Performed only via embryos formed via IVF
-May be taken from cells from a very early gestation
-A polar body from the zygote
-A blastomere
-A cell from the blastocyst
-Primarily used to identify known genetic conditions in the family
-Down syndrome
-Turner syndrome
-muscular dystrophy and cystic fibrosis
-Chromosomal structural rearrangements
-also performed in AMA pts undergoing IVF for aneuploidy (abnormal chromosomes) -> Controversial bc many false positive results
-Confirmation with chorionic villus sampling or amniocentesis is recommended due to scarcity of tissue and potential for error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

testing with chorionic villus sampling (CVS)

A

-1st trimester ONLY -> gives pt privacy if they decide to terminate pregnancy
-higher risk of loss at 2nd or 3rd -> DONT DO
-transcervical or transabdominal approach under US guidance
-results available in about a week
-1/3 of pts experience vaginal bleeding after transcervical CVS
-risk of infection or leakage of amniotic fluid is <0.5%
-loss of pregnancy (about 0.22% risk)
-used for abnormality on screening or US, or if pt prefers dx over screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

amniocentesis

A

-NEVER in 1st trimester bc risk of loss is much higher
-performed any time after 14 wks
-performed via transabdominal approach under US guidance
-fetal cells obtained in amniotic fluid
-karyotype is obtained
-results available in 7-14 days
-risk of pregnancy loss is approx 0.1-0.3%
-risk of leakage of amniotic fluid or vaginal bleeding is about 1-2%
-used for abnormality on screening or US, or if pt prefers dx over screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

karyotypes: of fetus with down syndrome (left) and of fetus with trisomy 13 (patau syndrome) (right)

A

obtained by CVS or amnio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when are results available for dx studies

A

-Preimplantation genetic dx: 1-2 days
-Karyotype: 7-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fluorescence in situ hybridization

A

-Yields results in 24-48 hours for amniocentesis and CVS
-results are only available for abnormalities in chromosomes 13, 18, 21, X and Y
-targets certain genes
-identify sex of fetus
-Should not be considered dx
-should be confirmation of results before being certain of dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

aneuploidy

A

-having too many or to few chromosomes
-MC- down syndrome (trisomy 21) -> 1:700 live births
-other common trisomes -> Edwards syndrome (trisomy 18) and platau syndrome (trisomy 13) -> both are incompatible with life
-risk of trisomy 21 increases with maternal age -> but more babies are born to younger parturients bc there are more babies born to younger pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

chromosomal abnormalities in 2nd trimester pregnancies based on maternal age at term

A

-any chromosomal anomaly 1:122
-by 40 its 1:40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dysmorphic features of downs syndrome

A

-Short stature
-Single palmar crease
-Flat nasal bridge
-Protruding tongue
-Upslanting palpebral fissures
-Bilateral epicanthal folds
-Small ears

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sonographic anomalies assoc with aneuploidy

A

-Cystic hygroma
-Hydrops
-Hydrocephalus
-Holoprosencephaly
-Cardiac defects
-Omphalocele
-Bowel obstruction
-Facial cleft
-Clubfoot

17
Q

asldkfjsda

A

cystic hygroma
-wt of the cyst can compress the trachea
-prepares you for the need for surgery

18
Q

holoprosencephaly with lemon sign

A

holoprosencephaly (cyclopia)- failure of forebrain to develop

19
Q

options for screening tests

A

-Noninvasive prenatal testing (NIPT)
-Nuchal translucency alone
-First trimester screening
-Second trimester quad screen
-Integrated (first and second trimester) screen

20
Q

NIPT screening for aneuploidy (cell-free DNA screening)

A

-highest detection rate of all screening test
-uses fetal cells and nucleic acids found in maternal circulation -> noninvasive with regard to fetus
-screen for common trisomies (down syndrome, patau syndrome, edwards syndrome, others)
-screens for sex
-fetal Rh status
-is NOT diagnostic
-results in 7-10 days

21
Q

who can have cell-free DNA screening (NIPT)

A

-pts with singleton gestations
-done between 10 wks until delivery
-pts with no evidence of a structural anomaly identified on US exam

22
Q

counseling of pts regarding cell free DNA (NIPT)

A

-explain benefits and limitations
-Its a screening test -> does NOT r/o aneuploidy
-tests only for aneuploidies and sex chromosome at the time of test
-indicated for low-risk pts with a singleton gestation and no known anomalies
-May or may not be covered by insurance
-ACOG does not recommend cell-free DNA for single-gene disorders such as sickle cell disease or cystic fibrosis because of insufficient data concerning accuracy

23
Q

nuchal translucency (NT)

A

-1st trimester
-Measures fluid in posterior neck
-Abnormal if NT >3 mm
-Sensitivity of NT and maternal age alone=72-77%
-Also abnormal in trisomy 13 and 18, cardiac anomalies

24
Q

first trimester screen

A

-Includes:
-Maternal serum:
-Pregnancy activated plasma protein A (PAPP-A)
-HCG
-Ultrasound (nuchal translucency)- NT scan
-10-13 weeks
-Detection rate for trisomy 21: 82-87%

25
Q

Quad screen

A

-maternal serum:
-HCG
-AFP- maternal serum
-Unconjugated estriol (uE3)
-Dimeric inhibin A (DIA)
-15-22 weeks (2nd trimester)
-Also screens for neural tube defects
-Detection rate for trisomy 21: 81%

26
Q

review of genetic screening options

A

-integrated screen- best rate for trisomy 21 -> rarely done

27
Q

neural tube defects

A

-MC types:
-Anencephaly
-0.1% of all American neonates annually
-F>M
-Incompatible with life
-Spina bifida
-1400 neonates annually
-May result in:
-Incontinence of bladder and/or bowel
-Paresthesia and paralysis
-Sexual dysfunction
-Arnold-Chiari malformation of the brain
-MC types
-Meningomyelocele (MC)
-Meningocele
-Spina bifida occulta (mildest form)

28
Q

anecephaly

A

-F>M

29
Q

prevention of neural tube defects

A

-All individuals capable of pregnancy who are not trying to avoid pregnancy should take folic acid 400 mcg daily